Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2018-07-16
2020-09-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Omega-3 and Whey Protein Supplementation on Lean Mass in Older Adults
NCT05862779
Effects of Protein Timing and Resistance Exercise on Fat Metabolism
NCT03573687
Protein and Exercise for Postmenopausal Women's Wellbeing
NCT06849817
Whey Protein Supplementation Associated With Resistance Training on Health Indicators in Trained Older Women
NCT03247192
Breakfast and Metabolism in Men
NCT03399812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
These participants will maintain their daily food and exercise routine and will receive no intervention.
No interventions assigned to this group
Whey Protein Supplementation
Participants will receive protein supplementation daily for 16 weeks.
Whey protein
Participants in the protein arms will receive whey protein daily for 16 weeks.
Omega-3 Fatty Acids (O3FA)
Participants will receive O3FA supplementation daily for 16 weeks.
Omega-3 fatty acids
Participants in the omega-3 fatty acid arms will receive capsules daily for 16 weeks.
Whey Protein and O3FA
Participants will receive protein and O3FA supplementation daily for 16 weeks.
Whey protein
Participants in the protein arms will receive whey protein daily for 16 weeks.
Omega-3 fatty acids
Participants in the omega-3 fatty acid arms will receive capsules daily for 16 weeks.
Whey Protein and Placebo Fat Source
Participants will receive protein and placebo fat source supplementation daily for 16 weeks.
Whey protein
Participants in the protein arms will receive whey protein daily for 16 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whey protein
Participants in the protein arms will receive whey protein daily for 16 weeks.
Omega-3 fatty acids
Participants in the omega-3 fatty acid arms will receive capsules daily for 16 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* diet restrictions
* do not habitually eat breakfast
* picky eaters\\regularly consume protein or omega-3 related supplements
* consume omega-3 fatty acid rich fish (tuna, salmon, etc.) greater than two times per month -have any other diet-related conditions that would prevent them from consuming whey protein supplements and/or omega-3 fatty acid supplements
* smoking
* habitual alcohol consumption (\> 4 drinks/week)
* medication impacting appetite or metabolism
* Lipid or blood pressure lowering medication
* Hormone replacement therapy
85 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arkansas, Fayetteville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jamie Baum
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamie I Baum, Phd
Role: PRINCIPAL_INVESTIGATOR
University of Arkansas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas
Fayetteville, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UArkansasFayetteville
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.